NEA (New Enterprise Associates)

Type

Venture Capital

Status

Active

Location

Menlo Park, United States

Total investments

2216

Average round size

38M

Portfolio companies

1174

Rounds per year

47.15

Lead investments

345

Follow on index

0.47

Exits

517

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyInternetSoftwareInformation TechnologyMobileHealth CareSaaSEnterprise SoftwareManufacturingMedical

Investor highlights

Industry focus
B2B/EnterpriseCybersecurityFintechEcommerceMedia/Content Show 2 more
Stage focus
GeneralistPre-SeedSeedSeries ASeries B Show 3 more
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 6200000000
Fund raised date
2023-01-26

Analytics

Total investments
2216
Lead investments
345
Exits
517
Rounds per year
47.15
Follow on index
0.47
Investments by industry
  • Software (596)
  • Health Care (465)
  • Biotechnology (369)
  • Information Technology (265)
  • Enterprise Software (241)
  • Show 482 more
Investments by region
  • United States (1968)
  • China (45)
  • United Kingdom (18)
  • Canada (21)
  • Germany (21)
  • Show 21 more
Peak activity year
2015
Number of Unicorns
89
Number of Decacorns
102
Number of Minotaurs
33

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
14
Avg. valuation at time of investment
765M
Group Appearance index
0.87
Avg. company exit year
9
Avg. multiplicator
5.00
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Amber Therapeutics 10 Jun 2024 Biotechnology, Therapeutics Early Stage Venture 109M England, London, United Kingdom
Xaira Therapeutics 23 Apr 2024 Early Stage Venture 1B United States, California, San Francisco
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.